Repeated doses of combined oral lysine acetylsalicylate and metoclopramide in the acute treatment of migraine.

Abstract:

:The combination of lysine acetylsalicylate and metoclopramide is effective in the treatment of migraine attacks. It was unknown whether repeated doses could improve efficacy. The aim of this open trial was to evaluate the effects of a second, and eventually a third dose of lysine acetylsalicylate and metoclopramide when a first dose of the treatment was ineffective. Patients were asked to take a second dose 2 hours after a first dose when they thought that the first dose was ineffective. They were allowed to take a third dose or their rescue medication 2 hours after the second dose when they judged that the treatment remained ineffective. Two hundred ninety-two patients were included in the study; 262 of the 292 patients treated 517 attacks. Headache relief (reduction in headache severity from grade 3 or 2 to grade 1 or 0) was observed in 54.8% of attacks after one dose, in 48.1% of attacks after a second dose, and in 40.3% of attacks after a third dose. Complete headache relief without recurrence and without use of a rescue medication was reported in 37% of the total attacks. The patients judged their treatment as good or excellent in 78% of attacks treated with one dose, in 41% of those treated with two doses, and in 19% of those treated with three doses. Tolerance, as judged by the patients, was considered good in 92% of treated attacks. Minor side effects occurred in 6% of attacks after a first dose, in 4.5% of attacks after a second dose, in 1.5% of attacks after a third dose, in 2% after unspecified delay, and in 14% overall. In conclusion, the efficacy of lysine acetylsalicylate and metoclopramide in the treatment of migraine attacks can be improved by repeated doses. It is well tolerated.

journal_name

Headache

journal_title

Headache

authors

Hugues FC,Lacoste JP,Danchot J,Joire JE

doi

10.1046/j.1526-4610.1997.3707452.x

subject

Has Abstract

pub_date

1997-07-01 00:00:00

pages

452-4

issue

7

eissn

0017-8748

issn

1526-4610

journal_volume

37

pub_type

临床试验,杂志文章,多中心研究

相关文献

HEADACHE文献大全
  • Migraine genetics--a review: Part I.

    abstract::Significant progress in molecular genetics has advanced our understanding of the genetic basis of migraine. The fundamentals of molecular genetics, and the recent advances in the field, are important for clinicians to understand, as they provide a foundation for critical appraisal of the literature, unprecedented insi...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.12156

    authors: Silberstein SD,Dodick DW

    更新日期:2013-09-01 00:00:00

  • Reduced sensitivity of lymphocyte beta-adrenergic receptors in migraine.

    abstract::Cyclic AMP (CAMP) accumulation induced by isoproterenol (IP) and forskolin in intact lymphocytes was determined in 12 patients with migraine and 12 healthy controls. Our data showed that IP CAMP accumulation (8.20 + 1.08 Pmol/million cells) was significantly (P = 0.033) lower than accumulation in the controls (14.39 +...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1993.hed33040198.x

    authors: Kuritzky A,Bennet E,Hering R,Ebstein R

    更新日期:1993-04-01 00:00:00

  • Chronic paroxysmal hemicrania and hemicrania continua: lack of efficacy of sumatriptan.

    abstract::Attacks of chronic paroxysmal hemicrania are prevented by the continuous administration of indomethacin. Sumatriptan, an agonist of 5-HT1-like receptors, has proven effective in the treatment of cluster headache attacks. There are clear clinical similarities between chronic paroxysmal hemicrania and cluster headache. ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1998.3803197.x

    authors: Antonaci F,Pareja JA,Caminero AB,Sjaastad O

    更新日期:1998-03-01 00:00:00

  • Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis.

    abstract:OBJECTIVES:This study aimed to survey the headache diagnoses and consequences among outpatients attending neurological services in 8 Asian countries. METHODS:This survey recruited patients who consulted neurologists for the first time with the chief complaint of headache. Patients suffering from headaches for 15 or mo...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究

    doi:10.1111/j.1526-4610.2008.01088.x

    authors: Wang SJ,Chung CS,Chankrachang S,Ravishankar K,Merican JS,Salazar G,Siow C,Cheung RT,Phanthumchinda K,Sakai F

    更新日期:2008-10-01 00:00:00

  • Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.

    abstract:OBJECTIVE:To confirm the efficacy of rizatriptan 10 mg orally disintegrating tablet (ODT) for the elimination of migraine-associated nausea. BACKGROUND:Pooled studies of rizatriptan analyzing elimination of nausea as a secondary endpoint showed that 65% of rizatriptan patients reported elimination of nausea at 2 hours...

    journal_title:Headache

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1111/j.1526-4610.2007.00954.x

    authors: Freitag F,Taylor FR,Hamid MA,Rodgers A,Hustad CM,Ramsey KE,Skobieranda F

    更新日期:2008-03-01 00:00:00

  • Differences in Topographical Pressure Pain Sensitivity Maps of the Scalp Between Patients With Migraine and Healthy Controls.

    abstract:OBJECTIVE:To investigate differences in topographical pressure pain sensitivity maps of the scalp between patients with migraine and healthy controls considering the chronicity (episodic/chronic) and side (strictly unilateral/bilateral) of the symptoms. BACKGROUND:It seems that the trigeminal area is sensitized in mig...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.12984

    authors: Barón J,Ruiz M,Palacios-Ceña M,Madeleine P,Guerrero ÁL,Arendt-Nielsen L,Fernández-de-Las-Peñas C

    更新日期:2017-02-01 00:00:00

  • Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.

    abstract:BACKGROUND AND OBJECTIVES:Certain neuromodulators, most notably topiramate (TPM) and divalproex sodium (DVP), are effective preventive agents for migraine. Published data from head-to-head studies comparing TPM and DVP are not available. The purpose of this study was to compare TPM and DVP for the prophyaxis of migrain...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1111/j.1526-4610.2011.01868.x

    authors: Krymchantowski AV,Jevoux CC

    更新日期:2011-04-01 00:00:00

  • Long-term, open-label safety study of oral almotriptan 12.5 mg for the acute treatment of migraine in adolescents.

    abstract:OBJECTIVES:This study evaluated the long-term safety of oral almotriptan 12.5 mg for the treatment of multiple migraine episodes in adolescents over a 12-month period. Efficacy outcomes were assessed as a secondary objective. METHODS:Adolescent migraineurs aged 12-17 years were enrolled in this 12-month, open-label st...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1111/j.1526-4610.2010.01655.x

    authors: Berenson F,Vasconcellos E,Pakalnis A,Mao L,Biondi DM,Armstrong RB

    更新日期:2010-05-01 00:00:00

  • Clinical, anatomical, and physiologic relationship between sleep and headache.

    abstract::The intimate relationship between sleep and headache has been recognized for centuries, yet the relationship remains clinically and nosologically complex. Headaches associated with nocturnal sleep have often been perceived as either the cause or result of disrupted sleep. An understanding of the anatomy and physiology...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2003.03055.x

    authors: Dodick DW,Eross EJ,Parish JM,Silber M

    更新日期:2003-03-01 00:00:00

  • A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study.

    abstract:BACKGROUND:Basilar-type migraine (BM) is the most common migraine "variant," representing 3-19% of migraine in children.BMis characterized by attacks of dizziness, vertigo, visual disturbances, ataxia, and/or diplopia, followed by migraine headache. OBJECTIVE:The objective of this study is to assess the efficacy and s...

    journal_title:Headache

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1111/j.1526-4610.2007.00867.x

    authors: Lewis D,Paradiso E

    更新日期:2007-11-01 00:00:00

  • Intracranial hypertension and levofloxacin: a case report.

    abstract::This is a case report of a 15-year-old boy who developed benign intracranial hypertension after 3 weeks of levofloxacin intake. The headache, diplopia, and papilledema resolved within a week after levofloxacin was withdrawn. Physicians must be aware that quinolone antibiotics can potentially cause intracranial hyperte...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2008.01212.x

    authors: Lardizabal DV

    更新日期:2009-02-01 00:00:00

  • Coping style and social support in men and women suffering from cluster headache or migraine.

    abstract:OBJECTIVE:To investigate similarities and differences between patients with cluster headache and patients with migraine. BACKGROUND:Patients with migraine and patients with cluster headache are considered, by many clinical neurologists, to be different psychologically and socially. METHODS:Twenty-five age-matched pai...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2002.02049.x

    authors: Blomkvist V,Hannerz J,Katz L,Theorell T

    更新日期:2002-03-01 00:00:00

  • Common CX3CR1 alleles are associated with a reduced risk of headaches.

    abstract:OBJECTIVES:The aim of this study was to investigate the role of the chemokine receptor CX3CR1 in headaches and migraine. METHODS:Distribution of 2 polymorphisms of the chemokine receptor CX3CR1 (V249I and T280M) was determined in a population-based sample of 1179 elderly individuals. RESULTS:Heterozygotes for both CX...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2007.01011.x

    authors: Combadière C,Godin O,Vidal C,Cangialosi A,Proust C,Tzourio C

    更新日期:2008-07-01 00:00:00

  • Migraine Headache Day Response Rates and the Implications to Patient Functioning: An Evaluation of 3 Randomized Phase 3 Clinical Trials of Galcanezumab in Patients With Migraine.

    abstract:OBJECTIVE:This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient-reported outcomes of health-related quality of life (HRQoL) and disability categories. BACKGROUND:Migraine causes considerable disease-related disability and negatively impacts H...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.14013

    authors: Ford JH,Kurth T,Starling AJ,Ayer DW,Wietecha LA,Port MD,Rettiganti M,Ruff DD

    更新日期:2020-11-01 00:00:00

  • Individual differences in the subjective experience of pain: new insights into mechanisms and models.

    abstract::Individual differences in pain sensitivity have long remained a perplexing and challenging clinical problem. How can one individual have a sensory experience that is vastly different than that of another, even when they have received similar sensory input? Developing an understanding of such differences and the mechan...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2010.01763.x

    authors: Coghill RC

    更新日期:2010-10-01 00:00:00

  • Ischemic colitis associated with naratriptan and oral contraceptive use.

    abstract::Ischemic colitis has not been reported in association with naratriptan therapy. We describe the occurrence of ischemic colitis in a patient who was treated with abortive doses of naratriptan for migraine and was also taking long-term oral contraceptives. Concurrent use of naratriptan and oral contraceptives should pro...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2005.05077_4.x

    authors: Charles JA,Pullicino PM,Stoopack PM,Shroff Y

    更新日期:2005-04-01 00:00:00

  • Traditional and alternative treatments for depression: implications for migraine management.

    abstract:BACKGROUND:Migraine is frequently comorbid with major depressive disorder, the presence of which confers increased disability and various clinical challenges. METHODS/RESULTS:The present article reviews empirically supported pharmacologic and cognitive-behavioral interventions for depression, as well as the emerging y...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.12521

    authors: Peck KR,Smitherman TA,Baskin SM

    更新日期:2015-02-01 00:00:00

  • Non-compliance with follow-up and improvement after treatment at a headache center.

    abstract::Two telephone surveys were conducted at a major headache center into patient compliance with follow-up and perceived treatment efficacy. The first survey addressed compliance with the recommendation to follow-up after the initial evaluation. Of a group of 316 consecutive patients, 40.5% had not complied with the recom...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1993.hed33040205.x

    authors: Spierings EL,Miree LF

    更新日期:1993-04-01 00:00:00

  • Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine.

    abstract:OBJECTIVE:To describe the pharmacokinetic and safety profiles of sumatriptan 85 mg formulated with RT Technology (RT) and naproxen sodium 500 mg in a fixed-dose combination tablet (sumatriptan/naproxen sodium) that targets both serotonergic dysmodulation and inflammation in migraine. METHODS:Six open-label, crossover ...

    journal_title:Headache

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1526-4610.2009.01606.x

    authors: Haberer LJ,Walls CM,Lener SE,Taylor DR,McDonald SA

    更新日期:2010-03-01 00:00:00

  • Episodic Syndromes That May Be Associated With Migraine: A.K.A. "the Childhood Periodic Syndromes".

    abstract::Previously called "childhood periodic syndromes that are commonly precursors of migraine" in International Headache Classification of Headache Disorders (ICHD)-II, these disorders were renamed "episodic syndromes that may be associated with migraine" in ICHD-III beta. The specific disorders reviewed in this article in...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.12624

    authors: Gelfand AA

    更新日期:2015-11-01 00:00:00

  • Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.

    abstract:BACKGROUND:Zonisamide, a sulfonamide analog, is an antiepileptic drug with mechanisms of action similar to topiramate. Because of its pharmacodynamic and pharmacokinetics profiles, zonisamide is also potentially suitable for migraine prevention. METHODS:Tolerability and effectiveness of zonisamide for migraine prophyl...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2010.01842.x

    authors: Villani V,Ciuffoli A,Prosperini L,Sette G

    更新日期:2011-02-01 00:00:00

  • Migraine prevalence and some related factors in Turkey.

    abstract:OBJECTIVES:The aim of our study is to determine the prevalence of migraine in Provincial Center of Edirne. METHODS:A systematic random sample of 386 inhabitants over 14 years old were interviewed face to face. Diagnosis of migraine was based on the International Headache Society (IHS) classification. RESULTS:Migraine...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.2005.05007.x

    authors: Celik Y,Ekuklu G,Tokuç B,Utku U

    更新日期:2005-01-01 00:00:00

  • Headache and self-assessed depression scores in Singapore University undergraduates.

    abstract::A self-administered questionnaire covering the diagnostic criteria of the International Headache Society was completed by 1208 undergraduates of the National University of Singapore to determine the prevalence and characteristics of headaches in this population. The relationship between headaches and depressive illnes...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.1997.3701026.x

    authors: Ho KH,Ong BK,Lee SC

    更新日期:1997-01-01 00:00:00

  • Application of metoclopramide specificity in migraine attacks therapy.

    abstract::The 5-HT3 antagonism property of metoclopramide, acting on receptors presumably located in the trigeminovascular system, is the theoretical basis of its remarkable success, as a single intravenous agent, in the treatment of migraine attacks. The specific anti-migraine activity of oral metoclopramide is, most probably,...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1994.hed3407439.x

    authors: Schwarzberg MN

    更新日期:1994-07-01 00:00:00

  • Nasal sprays for the treatment of migraine.

    abstract::If you vomit with migraines, get full-blown migraines upon awakening, or want rapid relief without injections, consider a nasal spray. Options include triptans (zolmitriptan [Zomig] or sumatriptan [Imitrex]), DHE (Migranal), or an NSAID (Sprix). ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/head.12045

    authors: Tepper DE

    更新日期:2013-03-01 00:00:00

  • Toward a standard drug formulary for the treatment of headache.

    abstract::The recent publication of drug formularies by third-party payers has serious implications for the practice of medicine. These formularies list the medications for which the consumer can be reimbursed by the third-party payer. The most restrictive of the five formularies I have received lists only two agents for the tr...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1111/j.1526-4610.1995.hed3504225.x

    authors: Klapper JA

    更新日期:1995-04-01 00:00:00

  • A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).

    abstract:OBJECTIVE:To evaluate the efficacy and safety of AVP-825, a drug-device combination of low-dose sumatriptan powder (22 mg loaded dose) delivered intranasally through a targeted Breath Powered device vs an identical device containing lactose powder (placebo device) in the treatment of migraine headache. BACKGROUND:Earl...

    journal_title:Headache

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/head.12472

    authors: Cady RK,McAllister PJ,Spierings EL,Messina J,Carothers J,Djupesland PG,Mahmoud RA

    更新日期:2015-01-01 00:00:00

  • Cognitive development in children with migraine and their healthy unaffected siblings.

    abstract::The discussion about neuropsychological sequalae from migraine occurring in adults is controversial. The purpose of our study was to examine whether children with migraine may be at risk for impaired intellectual development compared with their siblings free of migraine. ...

    journal_title:Headache

    pub_type: 杂志文章

    doi:10.1046/j.1526-4610.2002.02179.x

    authors: Haverkamp F,Hönscheid A,Müller-Sinik K

    更新日期:2002-09-01 00:00:00

  • Vascular risk in migraineurs: interaction of endothelial and cortical excitability factors.

    abstract:BACKGROUND:Migraine is a common primary headache disorder occurring predominantly in a young, relatively healthy population. RESULTS:There is a growing literature on associations between migraine, especially migraine with aura, and ischemic stroke as well as other vascular events. Migraine as a risk factor for vascula...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/head.12304

    authors: Murinova N,Krashin DL,Lucas S

    更新日期:2014-03-01 00:00:00

  • Migraine with and without aura: the same disease due to cerebral vasospasm of different intensity. A hypothesis based on CBF studies during migraine.

    abstract::The CBF studies performed so far during attacks of migraine, may be interpreted as favouring "the vascular theory." This applies to migraine with aura as well as to migraine without aura. Migraine without aura may be due to mild focal CBF reduction--too mild to be detected by the available CBF techniques (i.e. 20% or ...

    journal_title:Headache

    pub_type: 杂志文章,评审

    doi:10.1111/j.1526-4610.1990.hed3005269.x

    authors: Skyhøj Olsen T

    更新日期:1990-04-01 00:00:00